Will the mRNA flu shot work better than a regular seasonal one? What the science says

TL;DR - Moderna’s newly approved mRNA influenza vaccine could help manufacturers adapt seasonal shots more rapidly as circulating strains change. The provided excerpt does not report comparative efficacy against conventional flu vaccines.

• The vaccine uses mRNA technology for seasonal influenza.
• Its key stated advantage is faster responsiveness to changing flu strains.
• Whether it works better than conventional seasonal vaccines cannot be determined from the limited content provided.